FINEVISION HP Trifocal IOLs
Beaver-Visitec International, Inc. · Decision date Oct 27, 2026
What did the FDA decide?
FDA recorded a 30-Day Notice decision, OK30, dated 2026-10-27 for P240038/S004, a supplement to the FINEVISION HP Trifocal IOLs application held by Beaver Visitec International, Inc. The supplement type is a 30-Day Notice and the recorded reason is a process change affecting manufacturer, sterilizer, packager or supplier. The product is an intraocular lens in the Ophthalmic specialty under product code HQL.
The recorded statement describes a high-throughput optical inspection workflow for routine production of these trifocal intraocular lenses, using existing optical metrology integrated with lens-handling and automated data-processing systems. This entry covers the manufacturing process change only; it is not a new approval of the whole lens system. The source lists no supporting documents, so the inspection specifications, validation data and any effect on finished-device characteristics remain unknown.
Whether the change alters clinical performance or labeling cannot be determined from the available record, and no such conclusion is drawn here.
FDA approval order statement
a high-throughput optical inspection workflow in routine production of FINEVISION HP Trifocal Intraocular Lenses using existing optical metrologer integrated with lens-handling and automated data-processing systems
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Oct 27, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P240038/S004
- Regulatory pathway
- PMA supplement
- Applicant
- Beaver-Visitec International, Inc.
- Product code
- HQL
- Decision code
- OK30
- Decision date
- Oct 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: intraocular lens.
- Applicant
- Beaver-Visitec International, Inc.
- Product code
- HQL
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P240038. Subsequent supplements may change the device or its indications.
FDA decision timeline
P240038 · Original PMA
FINEVISION HP Trifocal IOLs
P240038/S003 · Related supplement
FINEVISION HP Trifocal IOLs
P240038/S004 received
Application receipt date recorded by FDA.
P240038/S004 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P240038. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240038
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FINEVISION HP Trifocal IOLsP240038 | Beaver-Visitec International, Inc. | PMA approval | Sep 10, 2025 | FDA |
FINEVISION HP Trifocal IOLsP240038/S003 | Beaver-Visitec International, Inc. | PMA supplement | Sep 25, 2026 | FDA |
Explore the linked device profile
Other records with product code HQL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CT LUCIA Intraocular Lenses (IOLs)P100016/S028 | Carl Zeiss Meditec Production, LLC | PMA supplement | Oct 23, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S067 | Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
enVista Hydrophobic Acrylic Intraocular LensP910056/S066 | Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Beaver-Visitec International, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 500 Totten Pond Rd., Waltham, MA, 02451
Sources and methodology
- Original FDA record: P240038/S004
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




